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Abstracts 215the ability of software BHC to remove density artefacts. Meaningful microCT
bone densitometry is possible provided that scans are made with suitable fil-
ter, appropriate BH correction is applied, x-ray absorption outside the cam-
era field of view (truncation) is minimal, and that as far as possible sample
(and calibration phantom) dimensions and mounting are standardised. Densi-
tometry is more accurate in the absence of surrounding media such as water
or tissue.
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Background: Natural herbal therapy offers an attractive alternative for
osteoporosis. The objective of this study is to evaluate the efficacy and
safety of natural Chinese herbs, Zuogui Pill (ZGP) and Yougui Pill (YGP),
for low bone mineral density (BMD).
Methods: 200 subjects were included double-blindly and randomly allocated
into two groups, treatment and control. All subjects were diagnosed with
low BMD and kidney deficiency in Traditional Chinese Medicine (TCM). Sub-
jects in treatment group were treated for 6 months with either ZGP or
YGP based on clinical characters of TCM, while control group received pla-
cebo for the same period of time. Primary outcome was lumbar BMD as
determined by using dual-energy X-ray absorptiometry. Secondary outcomes
included visual analogue scale (VAS), quality of life (ECOS-16), and serum
markers of bone metabolism. Adverse effects were documented for safety
assessment. Follow-ups were performed at regular intervals during a one-
year period.
Results: In ZGP group, lumbar BMD was increased by 4.1% immediately after
the treatment (P<0.05) and by 4.7% at the end of the additional 6-month
follow-up. Bone anabolic marker was also significantly improved after treat-
ment (P<0.05). In YGP group, the VAS and ECOS-16 scores were also signif-
icantly reduced after treatment (P<0.05). Furthermore, bone resorption
marker was significantly suppressed after treatment in YGP group
(P<0.05), and bone anabolic marker was significantly increased (P<0.05),
respectively. No severe adverse effects were observed.
Conclusion: ZGP and YGP are effective and safe therapeutic drugs for oste-
oporosis, which improve lumbar BMD, reduce pain intensity, alleviate bone
resorption, and stimulate bone formation.
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Menopause represents a period when many physiological changes develop
such as hypertension, a decrease in BMD, osteoarthritis and changes in bone
quality.Methods: In Department of Clinical Physiology and Pathology of Locomotor
Apparatus, Institute of Gerontology AMS Ukraine 115 women aged 46-78
(average age is 666,4) were subdivided into three groups: group I
comprised 42 patients with osteoarthritis roentgen phase II (Kellgren & Law-
rence, classification)), group II comprised 24 patients with hypertension sec-
ond degree, group III (13 women) with stage II osteoarthritis combined with
hypertension of the second degree. Bone mineral density (BMD) was deter-
mined by means of Dual-energy X-ray absorptiometer “Prodigy” (GE Medical
systems).
Results: BMD was decreased group III patients compared with women in I and
II group (0,97  0,05, 1,1  0,03 and 1,14  0,09 respectively p<0,05). This
indicates an violation bone quality due to influence of hypertension on bone
metabolism. The results point to necessity prescribe early treatment to
improve bone quality in group III women aged 60-80 years.
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Background: Diabetes affects over 170 million people globally. Peripheral
diabetic polyneuropathy is one of the more debilitating complications arising
from hyperglycemia, affecting 30-70 % of all diabetics and making it the
most prevalent painful neuropathy. Although diabetic neuropathy occurs
often and has characteristic clinical manifestations, it is typically poorly
diagnosed, especially in the early stages of the disease. Cellular and molec-
ular mechanisms of interaction of peripheral nervous system with a bone
metabolism till now poorly studied. Different screening methods have repro-
duced different results.
Aim: The aim of this study to assess the bone mineral density (BMD) of the
lower extremities in women in the postmenopausal period with diabetes
mellitus (DM) type 2 and its dependence from diabetic peripheral
polyneuropathy.
Method: This research have taken 51 women, average age 54,7  2,49 year
with DM type 2, of whom 29 were diagnosed with distal polyneuropathy of
the lower extremities. The control group consisted of 25 women, average
age 52,2  2,15 year with no risk factors for reduction in BMD. Clinical eval-
uation comprised clinical and neurologic status, questionnaire related to
osteoporosis (the Kanis, 2010), DN4, a visual analogue scale (VAS), scale
NISLL. BMD was determined by dual-energy x-ray absorptiometry (DXA)
(“Prodigy”, GE Medical systems).
Results: BMD (0.630.02) was significantly lower in patients with type 2 dia-
betes, complicated by distal polyneuropathy of the lower extremities,
compared with either patients without polyneuropathy (0.83 0,05
(pZ0.021)) or with healthy women (1.03  0.2 (pZ0.045)). This data con-
firms the impact of diabetic polyneuropathy on bone metabolism. Future
research will focus on these findings and comprise correlation with intensity
of pain syndromes to determine the value of a personalized treatment
approach.
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Background: Menopause is the special period in women’s life when many
physiological changes develop simultaneously, for example, hypertension,
decrease BMD, osteoarthritis, but, unknown how the quality of bone can
changes.
Methods: In Department of Clinical Physiology and Pathology of Locomotor
Apparatus, Institute of Gerontology AMS Ukraine 115 women aged 46-78
(average age is 666,4) were subdivided into three groups: group I
comprised 42 patients diagnosed with osteoarthritis (gonartritis) roentgen
phase II according to classification of Kellgren & Lawrence (1957), group II
comprised 24 patients with hypertension second degree, group III (13
women) with gonartritis of stage II in combination with hypertension of
